Revolution Medicines

Revolution Medicines RVMD Stock

$159.82   -1.764088%
Add to favorites
Market Cap
$34.57B
LOW - HIGH [24H]
$158.41 - $163.04
VOLUME [24H]
$1.80M
P/E Ratio
0
Earnings per share
-$9.13
ISIN
US76155X1000
Price   Prediction

Revolution Medicines Price Chart

Sorry, that's all we've gotfor now...

Revolution Medicines (RVMD) stock price today is 159.82 USD on Tech Market Large (-1.76% on the day). Updated .

Revolution Medicines RVMD Financial and Trading Overview

Revolution Medicines stock price 159.82 USD
Previous Close 166.87 USD
Open 166.87 USD
Bid 162.78 USD x 100
Ask 178.18 USD x 200
Day's Range 161.69 - 167.99 USD
52 Week Range 67.86 - 224.31 USD
Volume 2.69M USD
Avg. Volume 2.18M USD
Market Cap 35.19B USD
Beta (5Y Monthly) 1.431
PE Ratio (TTM) N/A
EPS (TTM) -9.13 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 274.68 USD

RVMD Valuation Measures

Enterprise Value 32.75B USD
Trailing P/E N/A
Forward P/E -51.6137
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 178.1169
Price/Book (mrq) 14.650159
Enterprise Value/Revenue 165.766
Enterprise Value/EBITDA -19.55

Trading Information

Revolution Medicines Stock Price History

Beta (5Y Monthly) 1.431
52-Week Change 136.42%
S&P500 52-Week Change 12.07%
52 Week High 224.31 USD
52 Week Low 67.86 USD
50-Day Moving Average 193.6 USD
200-Day Moving Average 160.23 USD

RVMD Share Statistics

Avg. Volume (3 month) 2.18M USD
Avg. Daily Volume (10-Days) 3.26M USD
Shares Outstanding 216.29M
Float 186.57M
Short Ratio 6.78
% Held by Insiders 1.83%
% Held by Institutions 98.12%
Shares Short 13.08M
Short % of Float 6.37%
Short % of Shares Outstanding 6.05%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -852.97%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -32.13%
Return on Equity (ttm) -93.56%

Income Statement

Revenue (ttm) 197.56M USD
Revenue Per Share (ttm) 0.97 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -1253687040 USD
EBITDA -1675138944 USD
Net Income Avi to Common (ttm) -1870535936 USD
Diluted EPS (ttm) -9.13
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.65B USD
Total Cash Per Share (mrq) 16.88 USD
Total Debt (mrq) 1.21B USD
Total Debt/Equity (mrq) 50.44 USD
Current Ratio (mrq) 8.36
Book Value Per Share (mrq) 11.105

Cash Flow Statement

Operating Cash Flow (ttm) -1431372032 USD
Levered Free Cash Flow (ttm) -886292352 USD

Profile of Revolution Medicines

Country United States
State CA
City Redwood City
Address 700 Saginaw Drive
ZIP 94063
Phone 650 481 6801
Website https://www.revmed.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 883

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Q&A For Revolution Medicines Stock

What is a current RVMD stock price?

Revolution Medicines RVMD stock price today per share is 159.82 USD.

How to purchase Revolution Medicines stock?

You can buy RVMD shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Revolution Medicines?

The stock symbol or ticker of Revolution Medicines is RVMD.

Which industry does the Revolution Medicines company belong to?

The Revolution Medicines industry is Biotechnology.

How many shares does Revolution Medicines have in circulation?

The max supply of Revolution Medicines shares is 216.29M.

What is Revolution Medicines Price to Earnings Ratio (PE Ratio)?

Revolution Medicines PE Ratio is now.

What was Revolution Medicines earnings per share over the trailing 12 months (TTM)?

Revolution Medicines EPS is -9.13 USD over the trailing 12 months.

Which sector does the Revolution Medicines company belong to?

The Revolution Medicines sector is Healthcare.

Revolution Medicines RVMD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24424.45 USD —
+0.39
6.08B USD — 24225.3 USD — 24538.78 USD — — 6.08B USD —
us US Tech Global Select Market Com NQGS US 12038.91 USD —
+0.46
— — 11933.12 USD — 12087.81 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 2942.97 USD —
+0.53
— — 2921.79 USD — 2965.84 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3640.95 USD —
+0.48
— — 3611.7 USD — 3667.39 USD — — — —
us US Tech Biotechnology NBI US 6973.66 USD —
-0.63
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1324.83 USD —
-0.6
— — 1322.85 USD — 1342.46 USD — — — —
$2.16T
Total marketcap
$71.41B
Total volume
BTC 58.01%   •   ETH 9.87%
Dominance
Select currency